Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma

Guardado en:
Detalles Bibliográficos
Autores principales: Sanju Cyriac, Ajith Toms, Sunitha Thomas
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/eb325987792a48099d094465812ff599
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb325987792a48099d094465812ff599
record_format dspace
spelling oai:doaj.org-article:eb325987792a48099d094465812ff5992021-11-12T00:02:41ZDurable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma2278-330X2278-430610.1055/s-0041-1731911https://doaj.org/article/eb325987792a48099d094465812ff5992021-11-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731911https://doaj.org/toc/2278-330Xhttps://doaj.org/toc/2278-4306Sanju CyriacAjith TomsSunitha ThomasThieme Medical and Scientific Publishers Pvt. Ltd.articleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENSouth Asian Journal of Cancer (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sanju Cyriac
Ajith Toms
Sunitha Thomas
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
format article
author Sanju Cyriac
Ajith Toms
Sunitha Thomas
author_facet Sanju Cyriac
Ajith Toms
Sunitha Thomas
author_sort Sanju Cyriac
title Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
title_short Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
title_full Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
title_fullStr Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
title_full_unstemmed Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
title_sort durable response with single-agent pembrolizumab in a patient with metastatic melanoma
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate 2021
url https://doaj.org/article/eb325987792a48099d094465812ff599
work_keys_str_mv AT sanjucyriac durableresponsewithsingleagentpembrolizumabinapatientwithmetastaticmelanoma
AT ajithtoms durableresponsewithsingleagentpembrolizumabinapatientwithmetastaticmelanoma
AT sunithathomas durableresponsewithsingleagentpembrolizumabinapatientwithmetastaticmelanoma
_version_ 1718431381936144384

Ejemplares similares